 There is no intracranial mass or abnormal parenchymal or meningeal enhancement to suggest metastatic disease. The basal cisterns are patent and no obstructing lesions are identified. There is patchy, scattered periventricular white matter FLAIR and T2 signal abnormality, likely related to small vessel ischemic disease. Moderate supratentorial and infratentorial parenchymal volume loss. The lateral, third, and fourth ventricles are prominent and size. There is no diffusion weighted abnormality to indicate acute ischemic stroke. There is no susceptibility weighted artifact to suggest hemorrhagic lesion. There are no areas of abnormal enhancement. The major intracranial vascular structures enhance normally.
1.No abnormal parenchymal or meningeal enhancement to suggest intracranial metastatic disease.2.There is ventriculomegaly which is at least predominantly related to moderate global parenchymal volume loss. Component of communicating hydrocephalus/NPH is not excluded and can be correlated with clinical findings.3.Mild chronic small vessel ischemic disease.